[1]
|
Chow, E., Cushing-Haugen, K.L., Cheng, G.-S., Boeckh, M., Khera, N., Lee, S.J., Leisenring, W.M., Martin, P.J., Mueller, B.A., Schwartz, S.M. and Baker, K.S. (2017) Morbidity and Mortality Differences between Hematopoietic Cell Transplantation Survivors and Other Cancer Survivors. Journal of Clinical Oncology, 35, 306-313.
https://doi.org/10.1200/JCO.2016.68.8457
|
[2]
|
Devlin, E.J., Denson, L.A. and Whitford, H.S. (2017) Cancer Treatment Side Effects: Ameta-Analysis of the Relationship between Response Expectancies and Experience. Journal of Pain and Symptom Man-agement, 54, 245-258.
https://doi.org/10.1016/j.jpainsymman.2017.03.017
|
[3]
|
Martins, P., Jesus, J., Santos, S., Raposo, L.R., Roma-Rodrigues, C., Baptista, P.V. and Fernandes, A.R. (2015) Heterocyclic Anticancer Compounds: Recent Advances and the Paradigm Shift towards the Use of Nanomedicine’s Tool Box. Molecules, 20, 16852-16891. https://doi.org/10.3390/molecules200916852
|
[4]
|
Zhou, P., Liu, Y., Zhou, L., Zhu, K., Feng, K., Zhang, H., Liang, Y., Jiang, H., Luo, C., Liu, M. and Wang, Y. (2016) Potent Antitumor Activities and Structure Basis of the Chiral β-Lactam Bridged Analogue of Combretastatin A-4 Binding to Tubulin. Journal of Medicinal Chemistry, 59, 10329-10334. https://doi.org/10.1021/acs.jmedchem.6b01268
|
[5]
|
Finke, P.E., Shah, S.K., Fletcher, D.S., Ashe, B.M., Brause, K.A., Chandler, G.O., Dellea, P.S., Hand, K.M., Maycock, A.L., Osinga, D.G., Underwood, D.J., Weston, H., Davies, P. and Doherty, J.B. (1995) Orally Active. β-Lactaminhibitors of Human Leukocyte Elastase. 3. Stereospecific Synthesis and Structure-Activity Relationships for 3, 3-Dialkylazetidin-2-ones. Journal of Medicinal Chemistry, 38, 2449-2462. https://doi.org/10.1021/jm00013a021
|
[6]
|
Buynak, J.D., Rao, A.S., Fod, G.P., Carver, C., Carver, C., Adam, G., Geng, B., Bachmann, B., Shobassy, S. and Lackey, S. (1997) 7-Alkylidenecephalosporin Esters as Inhibitors of Human Leukocyte Elastase. Journal of Medicinal Chemistry, 40, 3423-3433. https://doi.org/10.1021/jm970351x
|
[7]
|
Wu, G.G. (2000) A Concise Asym-metric Synthesis of a β-Lactam-Based Cholesterol Absorption Inhibitor. Organic Process Research & Development, 4, 298-300. https://doi.org/10.1021/op990196r
|
[8]
|
O’Boyle, N.M., Greene, L.M., Bergin, O., Fichet, J.B., McCabe, T., Lloyd, D.G., Zis-terer, D.M. and Meegan, M.J. (2011) Synthesis, Evaluation and Structural Studies of Antiproliferative Tubulin-Targeting Azet-idin-2-Ones. Bioorganic & Medicinal Chemistry, 19, 2306-2325. https://doi.org/10.1016/j.bmc.2011.02.022
|
[9]
|
Carr, M., Knox, A.J.S., Lloyd, D.G., Zisterer, D.M. and Meegan, M.J. (2016) Development of the -Lactam Type Molecular Scaffold for Selective Estrogen Receptor Modulator Action: Synthesis and Cytotoxic Effects in MCF-7 Breast Cancer Cells. Journal of Enzyme Inhibition and Medicinal Chemistry, 31, 117-130.
https://doi.org/10.1080/14756366.2016.1210136
|
[10]
|
Xing, B., Rao, J. and Liu, R. (2008) Novel Beta-Lactam Antibiotics Derivatives: Their New Applications as Gene Reporters, Antitumor Prodrugs and Enzyme Inhibitors. Mini-Reviews in Medicinal Chemistry, 8, 455-471.
|
[11]
|
Nuzzi, A., Fiasella, A., Ortega, J.A., Pagliuca, C., Ponzano, S., Pizzirani, D., Bertozzi, S.M., Ottonello, G., Tarozzo, G., Reggiani, A., Bandiera, T., Bertozzi, F. and Piomelli, D. (2016) Potent α-Amino-β-Lactam Carbamic Acid Ester as NAAA Inhibitors. Synthesis and Structure-Activity Relationship (SAR) Studies. European Journal of Medicinal Chemistry, 111, 138-159. https://doi.org/10.1016/j.ejmech.2016.01.046
|
[12]
|
Zeng, X.-H., Wang, H.-M., Yan, Y.-M. and Ding, M.-W. (2014) One-Pot Regioselective Synthesis of β-Lactams by a Tandem Ugi 4CC/SN Cyclization. Tetrahedron, 70, 3647-3652. https://doi.org/10.1016/j.tet.2014.04.033
|